Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
In this pilot study, the investigator will test the usefulness of gabapentin in treating some
of the symptoms associated with POTS. Gabapentin is FDA-approved to treat epilepsy and nerve
pain and works by reducing excessive activity in the nervous system. This medication has also
been shown to be effective in reducing bowel discomfort in patients with irritable bowel
syndrome, sleeplessness, and possibly migraine headache. The investigator has observed
positive results when prescribing gabapentin off-label to alleviate photosensitivity and
headaches in POTS patients. The aim of this pilot study is to better quantify what the
investigator has seen and evaluate whether it merits further study in a larger group.